Optiver Holding’s Genmab GMAB Stock Holding History

Optiver Holding’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-125,914	Closed	-$3.88M	–	2481
2025 Q4	$3.88M	Buy	+125,914	New	+$3.92M	﹤0.01%	404
2025 Q3	–	Sell	-155,954	Closed	-$3.22M	–	2774
2025 Q2	$3.22M	Buy	+155,954	New	+$3.2M	﹤0.01%	246
2025 Q1	–	Sell	-36,260	Closed	-$757K	–	1441
2024 Q4	$757K	Buy	+36,260	New	+$797K	﹤0.01%	403
2023 Q4	–	Sell	-9,824	Closed	-$346K	–	531
2023 Q3	$346K	Buy	+9,824	New	+$374K	﹤0.01%	420
2023 Q2	–	Sell	-96,269	Closed	-$3.64M	–	523
2023 Q1	$3.64M	Buy	+96,269	New	+$3.7M	﹤0.01%	335
2022 Q4	–	Sell	-133,978	Closed	-$4.3M	–	464
2022 Q3	$4.3M	Buy	133,978 +95,826	+251%	+$3.36M	﹤0.01%	212
2022 Q2	$1.24M	Sell	38,152 -35,251	-48%	-$1.14M	﹤0.01%	230
2022 Q1	$2.66M	Sell	73,403 -30,617	-29%	-$1.05M	﹤0.01%	190
2021 Q4	$4.27M	Buy	104,020 +66,910	+180%	+$2.79M	﹤0.01%	195
2021 Q3	$1.62M	Buy	+37,110	New	+$1.67M	﹤0.01%	194
2021 Q2	–	Sell	-81,058	Closed	-$2.66M	–	532
2021 Q1	$2.66M	Buy	+81,058	New	+$3.05M	﹤0.01%	129

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Optiver Holding's GMAB Position: Q1 2026 in Review

Optiver Holding sold out of Genmab (GMAB) in Q1 2026, closing a stake of 125,914 shares — an estimated $3.88M sold.

Optiver Holding first reported a position in GMAB in Q1 2021 and held it in 11 quarters. The position peaked at $4.3M in Q3 2022. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

Optiver Holding reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
Optiver Holding sold 125,914 Genmab shares in Q1 2026, an estimated $3.88M.
Optiver Holding first reported a position in Genmab in Q1 2021 and held it in 11 quarters.
Optiver Holding's Genmab position peaked at $4.3M in Q3 2022.
272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.